Text Size
36 studies found for:    Tardive Dyskinesia

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
2 Completed Risperidone and Olanzapine for the Schizophrenic Patients With Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Interventions: Drug: risperidone;   Drug: olanzapine
3 Completed Melatonin Treatment for Tardive Dyskinesia in Schizophrenia
Condition: Tardive Dyskinesia
Interventions: Drug: Melatonin;   Drug: Placebo
4 Completed Extract of Ginkgo Biloba and Tardive Dyskinesia
Conditions: Tardive Dyskinesia;   Schizophrenia
Interventions: Drug: Extract of Ginkgo Biloba (EGb-761 capsules);   Drug: Placebo
5 Completed Tardive Dyskinesia and Cognitive Function
Conditions: Tardive Dyskinesia;   Neurocognitive Function
Interventions: Drug: amisulpride;   Drug: Olanzapine;   Drug: Conventional antipsychotics
6 Unknown † Efficacy of Docosahexaenoic Acid on Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Dietary Supplement: Omega-3 fish oil capsules (including DHA);   Dietary Supplement: Placebo
7 Completed Treatment of Tardive Dyskinesia With Galantamine
Condition: Tardive Dyskinesia
Intervention: Drug: Galantamine
8 Recruiting NBI-98854 Dose Titration Study for the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
9 Completed Efficacy and Safety of NBI-98854 in Subjects With Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: NBI-98854
10 Completed Piracetam for Treatment Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention: Drug: piracetam
11 Recruiting Safety and Efficacy of Pyridoxal 5' -Phosphate in the Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: Pyridoxal 5'-Phosphate;   Drug: Placebo
12 Recruiting NBI-98854 for the Treatment of Tardive Dyskinesia in Subjects With Schizophrenia or Schizoaffective Disorder (KINECT Study)
Condition: Tardive Dyskinesia
Interventions: Drug: NBI-98854;   Drug: Placebo
13 Completed Levetiracetam in the Treatment of Neuroleptic-induced Tardive Dyskinesia
Condition: Dyskinesia, Medication-Induced
Intervention: Drug: Levetiracetam
14 Recruiting D-Serine Treatment For Tardive Dyskinesia
Conditions: Schizophrenia and Schizoaffective Disorder;   Tardive Dyskinesia
Intervention: Dietary Supplement: D-serine
15 Terminated Sarizotan in the Treatment of Neuroleptic-Induced Tardive Dyskinesia
Condition: Neuroleptic-Induced Tardive Dyskinesia
Intervention: Drug: Sarizotan
16 Completed Effects of Atypical Versus Conventional Antipsychotics on the Prevalence of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Intervention:
17 Completed Ethyl-Eicosapentaenoic Acid and Tardive Dyskinesia
Conditions: Dyskinesia;   Schizophrenia
Intervention: Drug: eicosapentaenoic acid
18 Unknown † Aripiprazole for Neuroleptic-Induced Tardive Dyskinesia
Condition: Dyskinesia, Drug-Induced
Intervention: Drug: aripiprazole
19 Completed Levetiracetam Treatment of Tardive Dyskinesia
Condition: Tardive Dyskinesia
Interventions: Drug: levetiracetam;   Drug: placebo
20 Recruiting The Assessment of Movement Disorders Utilizing Live Two-Way Video
Condition: Tardive Dyskinesia
Intervention: Other: Two way video assessment
To Top

Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results
† Indicates status has not been verified in more than two years